Marlowe Partners’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-191,404
Closed -$13M 9
2021
Q1
$13M Hold
191,404
7.67% 6
2020
Q4
$14M Buy
191,404
+20,460
+12% +$1.48M 7.51% 6
2020
Q3
$12M Sell
170,944
-68,929
-29% -$5.41M 6.96% 6
2020
Q2
$17.5M Buy
239,873
+13,399
+6% +$954K 10.38% 3
2020
Q1
$14M Buy
226,474
+43,509
+24% +$2.66M 9.47% 4
2019
Q4
$12M Sell
182,965
-76,456
-29% -$5.25M 6.22% 7
2019
Q3
$20.5M Buy
259,421
+54,678
+27% +$3.65M 11.19% 3
2019
Q2
$11.8M Buy
204,743
+127,569
+165% +$7.48M 6.83% 7
2019
Q1
$4.05M Buy
+77,174
New +$4.04M 2.81% 9

Other funds holding CONE

Marlowe Partners's CONE Position: Q2 2021 in Review

Marlowe Partners sold out of CyrusOne Inc Common Stock (CONE) in Q2 2021, closing a stake of 191,404 shares — an estimated $13M sold.

Marlowe Partners first reported a position in CONE in Q1 2019 and held it in 9 quarters. The position peaked at $20.5M in Q3 2019. 419 funds tracked by Wall St. Rank hold CONE as of Q2 2021.

  • Marlowe Partners reported no remaining CyrusOne Inc Common Stock position as of Q2 2021 after selling out during the quarter.
  • Marlowe Partners sold 191,404 CyrusOne Inc Common Stock shares in Q2 2021, an estimated $13M.
  • Marlowe Partners first reported a position in CyrusOne Inc Common Stock in Q1 2019 and held it in 9 quarters.
  • Marlowe Partners's CyrusOne Inc Common Stock position peaked at $20.5M in Q3 2019.
  • 419 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q2 2021.

Based on Marlowe Partners's 13F filing for Q2 2021, filed 13 Aug 2021.